Innovative Strategies for Long-Term Management of Rosacea
By
Martin Schaller
Belinda Welsh
Giuseppe Micali
Jerry Tan
James Del Rosso
Julie Harper
Thomas Dirschka
Soyun Cho
Luiz M. C. Almeida
Khen Kon
Wioletta Barańska-Rybak
Johannes Dayrit
Linda Stein Gold
December 12, 2025
Clinical Scorecard: Innovative Strategies for Long-Term Management of Rosacea
At a Glance
Category Detail
Condition Rosacea Key Mechanisms Chronic inflammatory skin condition influenced by genetic and environmental factors, dysregulation of immune systems. Target Population Individuals diagnosed with rosacea, including various phenotypes. Care Setting Dermatology and non-dermatology healthcare settings.
Key Highlights
Need for streamlined approaches in long-term rosacea management. Importance of patient self-management and understanding of triggers. Recognition of rosacea as a chronic but manageable condition. Emphasis on clear communication between patients and healthcare professionals. Development of a comprehensive management pathway by the REACH GSC. Guideline-Based Recommendations
Diagnosis
Utilize patient self-assessments and standardized questionnaires for accurate diagnosis. Management
Implement a step-by-step management pathway addressing self-management, diagnosis, treatment selection, and maintenance. Monitoring & Follow-up
Regularly assess patient progress and modify management based on triggers and comorbidities. Risks
Misdiagnosis and suboptimal treatment due to inadequate patient profiling. Patient & Prescribing Data
Patients with varying phenotypes of rosacea.
Long-term control requires effective maintenance therapy beyond clinical trial durations.
Clinical Best Practices
Engage patients in their own long-term care to improve outcomes. Incorporate tools and questionnaires to facilitate clinical decision-making. Educate patients about the chronic nature of rosacea to enhance self-management. References
